CAS: 58856-93-2 - zymosan A from saccharomyces cerevisiae
Zymosan A
CAS:58856-93-2
Zymosan A, derived from Saccharomyces cerevisiae, is a TLR2 agonist and exhibits significant radioprotective effects, …
Ref: TM-T78101
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 11 Jul 2024
Zymosan A
CAS:58856-93-2
Formula:
C18H32O16
Color and Shape:
White to light-tan powder
Molecular weight:
504.44
Ref: 7W-GP3626
| Undefined size | To inquire |
Estimated delivery in United States, on Thursday 11 Jul 2024
Ref: 54-BIB6282
| 1g | 228.00 € | ||
| 5g | 707.00 € | ||
| 500mg | 145.00 € |
Estimated delivery in United States, on Wednesday 17 Jul 2024
Zymosan A
CAS:58856-93-2
Zymosan is prepared from the cell walls of baker’s yeast (Saccharomyces cerevisiae) and consists of …
Color and Shape:
Powder
Ref: 3D-OZ139261
| 1g | 113.00 € | ||
| 5g | 353.00 € | ||
| 10g | 492.00 € | ||
| 25g | 977.00 € | ||
| 2500mg | 212.00 € |
Estimated delivery in United States, on Tuesday 23 Jul 2024
Zymosan A (from Saccharomyces cerevisiae)
CAS:58856-93-2
Zymosan is prepared from the cell walls of bakerâs yeast (Saccharomyces cerevisiae) and consists of …
Ref: 3D-Z-9500
| 1g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 25g | To inquire | ||
| 2500mg | To inquire |
Estimated delivery in United States, on Tuesday 23 Jul 2024
